Infection with Zika virus (ZIKV) was recently demonstrated to be associated with damage to the central nervous system, especially microcephaly and the Guillain-Barré syndrome. This finding had alarmed public health agencies and mobilized institutions around the world to search for more information about the virus, its effects, pathophysiological mechanisms, and potential immunizations and treatments. Given the increasing interest in using iPSCs and cerebral organoids to model the congenital infection and neuropathogenesis induced by ZIKV, the aim of this review was to present an up-to-date summary of the publications on the association of ZIKV with microcephaly, using iPSCs and organoids. According to our review, the number of studies has decreased concomitantly with a decrease in the number of cases. The presence of subclinical lesions at birth, which may eventually present cognitive or behavioral problems in the future, suggests that persistent research efforts on the virus should be undertaken by the global health community till the threat is completely wiped out.
Health of Brazil, which described these cases as Zika Virus Congenital Syndrome. 8, 11 Infection with ZIKV during all the trimesters of pregnancy has been associated with fetal anomalies. The highest risk of severe fetal sequelae occurs with infection during the first and second trimesters and may occur among pregnant women with clear symptoms of the disease as well as the asymptomatic ones. 12 The major outcomes include fetal death, microcephaly, cerebral calcifications (parenchymal, periventricular, thalamic, and basal ganglia), ventriculomegaly, hydranencephaly, retardation of growth and neuropsychomotor development, ocular alterations, fetal hydrops, and auditory defects. 13 The induced pluripotent stem cells (iPSCs) is a relatively recent technique discovered in 2006. 14 hippocampus. 24 In the context of an emerging disease, the use of iPSCs and organoid is a powerful approach to model and study the disease and offers various advantages as well as challenges. There is an increasing interest in the use of iPSCs and cerebral organoids to model congenital infection and neuropathogenesis induced by ZIKV.
Due to the accumulating knowledge, the aim of this review was to present an up-to-date summary of the publications related to ZIKVassociated with microcephaly, using iPSCs and organoids.
| EMBRYONIC MODEL FOR IN VITRO STUDIES
The study of the neurological and neuropsychiatric disorders poses a major challenge for researchers. Despite significant investment in this field, there is a lack of predictive preclinical models that can be used to study the pathophysiology and mechanism of a disease, identify the therapeutic targets and test new drugs. 15 Although animal models are valuable in elucidating diseases and targeting markers and genes related to certain pathologies, they are ineffective when it comes to the application of the therapeutic discovery in human use. 16 The importance of using human cells for the study of diseases is evident from the number of drugs that are efficacious and safe when tested in animal models but fail in clinical trials. This may be partly attributed to differences between species. 17 Studies using tissue from autopsies may offer a great indicator of structural changes in the brain at the cellular and molecular level. The fact that about 90% of the drugs approved in such experimental models are no longer rejected due to efficacy failures or unexpected discovery of toxicity at the clinical trial stage confirms the importance of human tissues in such studies. 18, 19 The models of diseases that faithfully represent actual human diseases and their physiological peculiarities are needed to improve the success rate of newly discovered drugs. The development of organoids is an innovative in vitro technique that is expanding owing to its high therapeutic and investigative implication. Characterized as a three-dimensional biological structure, it is able to accurately reproduce developmental events in vivo.
Organoids have already been developed to model various organs such as the retina, gut, thyroid, liver, kidney, inner ear, and various regions of the brain. 24, 25 Organoids may be derived from iPSCs or progenitors of various organs. Similar to in vivo organogenesis, organoids self-organize by cell separation and are spatially restricted according to the lineage of the precursor cells. They can be used to model diseases, drug testing, and in the future, even tissue replacement. 25 Lancaster and Knoblich have described a method for the generation of cerebral organoids from iPSCs. 25 This protocol has allowed the generation of cerebral organoids from reprogrammed cells of patients with different pathologies, which signified a cuttingedge technology in the investigation of the mechanisms involved in pathogenesis. 25 It also made the reproduction of genetic disorders possible through the use of iPSCs from the affected patients or by introducing mutations or deletions of genes into cells of healthy patients. In cases of microcephaly caused by genetic mutations, for example, mini-brains were generated from iPSCs derived from the skin fibroblasts of an affected patient. The generated organoids resembled the phenotype of microcephaly, being much smaller in comparison to the mini-cerebros generated from cells of control patients. 24 
| CURRENT RESEARCH SCENARIO
The use of iPSCs and cerebral organoids to model congenital infection and neuropathogenesis induced by ZIKV is a subject of increasing interest. However, a long path of research and studies must still be traveled. Table 1 Further, using an iPSCs approach, hNPCs were used in a study to investigate the deleterious effects of ZIKV infection. The findings indicated that the Brazilian ZIKV strain was highly lethal to the human neural stem/progenitor cells which expressed the transcription factor Sox2. The study suggested that ZIKV may cause microcephaly by depleting the founder population of Sox2 + NPC, which are highly susceptible to the virus. 42 Another study used human cortical neural precursor cells derived from iPSCs as a direct ZIKV target to show that the strain MR766 of the ZIKV, serially passaged in monkey and mosquito cells, efficiently infected the hNPCs. Also, a tractable experimental model system was established to investigate the impact and mechanism of ZIKV on human brain development and provide a platform to screen therapeutic compounds. 43 It is important to emphasize that the morphology and characteristics of iPSCs are similar to embryonic stem cells (ESCs). Li et al 17, 18 and Dang et al 38 The ZIKV was first detected in Brazil in 2015, coinciding with a significant increase in the number of neonates with microcephaly.
The results of different tests have already been considered strong enough to establish a relationship between infection of the mother with ZIKV and fetal microcephaly, among other brain anomalies. 44, 45 This evidence indicates that ZIKV is highly neuropathological, with devastating and irreparable consequences, especially in fetuses.
The main focus of the current studies, from cell culture techniques to animal models, is to investigate the mechanisms by which ZIKV acts in the brains of fetuses. They report that ZIKV infection in neural progenitors derived from human stem cells, neurospheres, and organoids causes cytotoxic effects mainly related to growth attenuation and cell death. 34, 38, 40, 43, 46 In the animal models, some of which were immunocompromised, ZIKV infections demonstrated a number of characteristics common to those occurring in humans, including transplacental transmission and neuropathology in both the adult and fetal brain. and microcephaly using iPSCs and organoids. According to our review, the number of such studies has reduced with a decrease in the number of cases. Considering prenatal subclinical lesions which may eventually present cognitive or behavioral problems in the future, the global health community should not let this virus fade from the research agenda until the threat is wiped out completely.
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